Embrace Hydrogel Embolic System
Phase 3- Indications
- Peripheral vascular embolotherapy, Interventional oncology
Company intelligence / Profile preview
Instylla
Bedford, Massachusetts, United Statesinstylla.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Instylla’s Embrace™ Hydrogel Embolic System completed pivotal study enrollment in 2024 and submitted its final PMA module to the FDA in March 2025 for the indication of hypervascular tumor embolization. The Tembo™ Embolic System received FDA 510(k) clearance in January 2025 as a bioresorbable gelatin particle embolic agent for peripheral vascular applications.
- Therapeutic areas
- OncologyCardiovascularHematology
- Modalities
- DeviceHydrogel-based drug delivery therapy (for Embrace™ Hydrogel Embolic System)Bioresorbable embolic agent (for Tembo™ Embolic System)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed.
Beyond the preview
Go deeper on Instylla.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Instylla.